ArticleProtein science : a publication of the Protein Society2026
Diversity of FAAL enzymes and prediction of their substrate specificity using FAALPred.
Article in Protein science : a publication of the Protein Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diversity of FAAL enzymes and prediction of their substrate specificity using FAALPred.Protein science : a publication of the Protein Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
FAALs (fatty acyl-AMP ligases) recruit and incorporate fatty acids during the biosynthesis of secondary metabolites. Their diversity, distribution, and substrate specificity remain poorly understood, which limits functional predictions from sequence data. In this study, we explored the prevalence and diversity of FAAL enzymes across the tree of life and show that these are widely distributed in secondary metabolite-rich bacteria and predominantly in the context of polyketide and non-ribosomal peptide biosynthetic pathways. FAALs were also found to be present in certain archaea and eukaryotic groups. The phylogenetic placement of FAALs was not correlated to the chain length of the fatty acids that they activate and load. Therefore, we developed a bioinformatics and AI workflow (FAALPred) to predict the chain length of the fatty-acid substrate of a given FAAL sequence. The robustness and accuracy of the predictions generated by FAALPred were validated using independent in vitro and in silico data. We anticipate that FAALPred will not only accelerate secondary metabolite structural predictions and subsequent discovery from FAAL-associated pathways but also facilitate engineering of lipoylation. FAALPred is available at https://faalpred.ciimar.up.pt/.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.